ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 7555439

Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction.

Verne GN and 3 others. Dig Dis Sci, 1995. Cited by 116 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction. Papers, record 7555439. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7555439

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction.
PubMed
Journal
Dig Dis Sci
PubMed
Year
1995
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
116
iCite
Relative citation ratio, by iCite
4.74
iCite
Revised in PubMed
2026-10-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Verne GNG N
2Eaker EYE Y
3Hardy EE
4Sninsky CAC A

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ErythromycinMajor topic
Gastrointestinal AgentsMajor topic
Intestinal Pseudo-ObstructionMajor topic
OctreotideMajor topic
Scleroderma, SystemicMajor topic
Adult
Aged
Aged, 80 and over
Drug Therapy, Combination
Female
Gastrointestinal Motility
Humans
Male
Manometry
Middle Aged
Prospective Studies

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01324895Retrospective Analysis of Treatment Outcomes in Patients With Bacterial Overgrowth Syndrome Diagnosed by D-Xylose Breath TestingBackground

Source ClinicalTrials.gov

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13,058,442Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: a double-blind, placebo-controlled study.Dig Dis Sci1988https://conductscience.org/library/papers/3058442PubMed
21,944,424Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.N Engl J Med1991https://conductscience.org/library/papers/1944424PubMed
32,883,059Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man.Digestion1987https://conductscience.org/library/papers/2883059PubMed
47,797,125Differential regional effects of octreotide on human gastrointestinal motor function.Gut1995https://conductscience.org/library/papers/7797125PubMed
53,227,290Effect of the long-acting somatostatin analogue SMS 201-995 on small-intestinal interdigestive motility in the dog.Scand J Gastroenterol1988https://conductscience.org/library/papers/3227290PubMed
62,910,760Rectosigmoid motility and myoelectric activity in progressive systemic sclerosis.Gastroenterology1989https://conductscience.org/library/papers/2910760PubMed
7864,008The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine.J Clin Invest1977https://conductscience.org/library/papers/864008PubMed
86,144,609Effect of somatostatin and atropine infusion on intestinal transit time and fructose absorption in the perfused human jejunum.Diabetes1984https://conductscience.org/library/papers/6144609PubMed
96,333,163Radiologic and histologic differentiation of neuromuscular disorders of the gastrointestinal tract: visceral myopathies, visceral neuropathies, and progressive systemic sclerosis.AJR Am J Roentgenol1984https://conductscience.org/library/papers/6333163PubMed
106,148,290Somatostatin induces ectopic activity fronts of the migrating motor complex via a local intestinal mechanism.Gastroenterology1984https://conductscience.org/library/papers/6148290PubMed

1 to 10 of 45

See all 45 references

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 116 citations.

PMIDTitleJournalYearIn PapersSource
41,907,233Severe scleroderma colopathy at initial diagnosis of systemic sclerosis in a young man: a case report.Front Med (Lausanne)2026https://conductscience.org/library/papers/41907233PubMed
38,406,978Managing gastrointestinal manifestations in systemic sclerosis, a mechanistic approach.Expert Rev Clin Immunol2024https://conductscience.org/library/papers/38406978PubMed
38,057,499Neurogastroenterology and Motility Disorders of the Gastrointestinal Tract in Cystic Fibrosis.Curr Gastroenterol Rep2024https://conductscience.org/library/papers/38057499PubMed
36,688,692Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis.Rheumatology (Oxford)2023https://conductscience.org/library/papers/36688692PubMed
32,826,308The management of adult patients with severe chronic small intestinal dysmotility.Gut2020https://conductscience.org/library/papers/32826308PubMed
32,437,393Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial.PLoS One2020https://conductscience.org/library/papers/32437393PubMed
32,078,071Small Bowel Dysmotility, Pseudoobstruction, and Functional Correlation with Histopathology: Lessons Learned.Curr Gastroenterol Rep2020https://conductscience.org/library/papers/32078071PubMed
31,636,773Functional, Diagnostic and Therapeutic Aspects of Gastrointestinal Hormones.Gastroenterology Res2019https://conductscience.org/library/papers/31636773PubMed
30,057,856Gastrointestinal Manifestations of Systemic Sclerosis.Rheumatology (Sunnyvale)2018https://conductscience.org/library/papers/30057856PubMed
29,464,583Intestinal Involvement in Systemic Sclerosis: A Clinical Review.Dig Dis Sci2018https://conductscience.org/library/papers/29464583PubMed

1 to 10 of 34

See all 34 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7555439

GET https://conductscience.org/api/papers/v1/7555439/references?page=2

API referenceFor AI assistants